Lai, Junyun https://orcid.org/0000-0001-5884-2786
Chan, Cheok Weng
Armitage, Jesse D.
Audsley, Katherine M.
Huang, Yu-Kuan
Derrick, Emily B. https://orcid.org/0000-0001-7191-3948
Carstensen, Laura S. https://orcid.org/0000-0002-3410-281X
Scheffler, Christina M. https://orcid.org/0000-0003-3731-6204
Jones, Matt E.
Sek, Kevin https://orcid.org/0000-0003-4634-7600
Principe, Nicola
Kim, Joelle S. https://orcid.org/0000-0001-9213-6180
House, Imran G.
Chen, Amanda X. Y. https://orcid.org/0000-0002-1388-9510
Yap, Kah Min https://orcid.org/0000-0001-5009-9895
Middelburg, Jim
Munoz, Isabelle https://orcid.org/0000-0001-6510-5696
Nguyen, Dat https://orcid.org/0009-0009-0702-0446
Tong, Junming
Hoang, Thang X.
Todd, Kirsten L. https://orcid.org/0000-0002-3903-166X
Evrard, Maximilien https://orcid.org/0000-0002-2105-1160
Chee, Jonathan https://orcid.org/0000-0002-7986-2708
Mackay, Laura K. https://orcid.org/0000-0002-8496-6632
Forrest, Alistair R. R.
Parish, Ian A. https://orcid.org/0000-0003-3528-478X
Bosco, Anthony https://orcid.org/0000-0002-4335-615X
Waithman, Jason https://orcid.org/0000-0003-4940-0155
Beavis, Paul A. https://orcid.org/0000-0002-2116-013X
Darcy, Phillip K. https://orcid.org/0000-0002-5303-9561
Article History
Received: 16 February 2025
Accepted: 7 January 2026
First Online: 10 February 2026
Competing interests
: P.A.B. declares research funding from Bristol-Myers-Squibb. P.K.D. declares research funding from CREATE Medicines, Prescient Therapeutics, Bristol-Myers-Squibb and INOVIQ. I.A.P. declares research funding from AstraZeneca, Bristol-Myers-Squibb and Roche Genentech. P.A.B. and P.K.D. declare the following patent related to this work. PCT/AU2019/050660 ‘Modified T cells and uses thereof.’ The other authors declare no competing interests.